Adaptive Biotechnologies: Review Finds Best Outcome for Shareholder Value Is to Operate MRD and Immune Medicine Businesses Internally >ADPT
Adaptive Biotechnologies: Review Finds Best Outcome for Shareholder Value Is to Operate MRD and Immune Medicine Businesses Internally >ADPT
自適應生物技術：審查發現實現股東價值的最佳結果是在內部運營MRD和免疫醫學業務 >ADPT
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊